Rxo (RXO) Total Debt (2022 - 2026)

Rxo (RXO) has 5 years of Total Debt data on file, last reported at $447.0 million in Q1 2026.

• For the quarter ending Q1 2026, Total Debt rose 10.64% year-over-year to $447.0 million; the trailing twelve-month figure through Mar 2026 stood at $447.0 million (up 10.64% YoY), and the FY2025 full-year result was $404.0 million, up 9.78% from the prior year.
• Total Debt for Q1 2026 stood at $447.0 million, up from $404.0 million in the prior quarter.
• Across five years, Total Debt topped out at $455.0 million in Q4 2022 and bottomed at $11.0 million in Q3 2022.
• The 5-year median for Total Debt is $403.0 million (2025), against an average of $382.5 million.
• Peak annual rise in Total Debt reached 4027.27% in 2023, while the deepest fall reached 21.1% in 2023.
• A 5-year view of Total Debt shows it stood at $455.0 million in 2022, then declined by 21.1% to $359.0 million in 2023, then increased by 2.51% to $368.0 million in 2024, then increased by 9.78% to $404.0 million in 2025, then rose by 10.64% to $447.0 million in 2026.
• The last three Total Debt figures came in at $447.0 million (Q1 2026), $404.0 million (Q4 2025), and $403.0 million (Q3 2025), per Business Quant data.

Peer Comparison